About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Panel Q&A
By
Michigan Medicine
FEATURING
Ammar Hassan
,
Hari Conjeevaram
,
Alisa Likhitsup
By
Michigan Medicine
FEATURING
Ammar Hassan
,
Hari Conjeevaram
,
Alisa Likhitsup
16 views
November 9, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
05:11
Novartis Cardiology
Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…
Feat.
R. Sugumaran,
P. Shah,
S. Shugg
Featured Video
02:17
Novartis Cardiology
Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…
Feat.
B. Buell
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
26:57
Houston Methodist
Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…
Feat.
T. R. Mccarty
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
21:33
AdventHealth
FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor A…
Feat.
R. Pratley
18:46
Houston Methodist
MAFLD: What Is It?
Feat.
D. Victor
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
26:49
Diana Isaacs
Tirzepatide Updates
08:35
Susan Brian
Labs to Check on Semaglutide or Tirzepatide
20:24
Diana Isaacs
Tirzepatide for Type 2 Diabetes
07:41
Susan Brian
Weightloss in Menopause
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
32:27
Scripps Health
Obesity: A Serious Cardiovascular Risk Factor? A Review of GLP-1 Rec…
Feat.
L. Vincent
36:34
Scripps Health
GLP-1 Hysteria
Feat.
S. Harris
25:25
Icahn School of Medicine at Mount Sinai
NASH Update 2023
Feat.
M. B. Bansal
43:23
MedNews Week
Best Practices In Managing NAFLD / NASH
Feat.
D. Bernstein
49:21
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
Feat.
S. Boushahri,
D. Lazzam,
K. MacEachern